- Home
- NFJ vs IART Comparison
NFJ vs IART Comparison
Compare NFJ & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFJ | IART |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NFJ | IART |
|---|---|---|
| Price | $13.29 | $14.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 223.5K | ★ 768.4K |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 9.01% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,642,966,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | N/A | $2.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $10.45 | $10.87 |
| 52 Week High | $12.86 | $27.13 |
Technical Indicators
Market Signals| Indicator | NFJ | IART |
|---|---|---|
| Relative Strength Index (RSI) | 66.46 | 64.55 |
| Support Level | $12.83 | $11.86 |
| Resistance Level | $13.02 | $12.83 |
| Average True Range (ATR) | 0.10 | 0.52 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 95.59 | 96.90 |
Price Performance
Historical ComparisonAbout NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.